Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3019768	s-cobuab	— (—)	247	282	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Fever of other and unknown origin

118

17.99

139.78

1.2

1.1

—

Bacterial infection, other or unspecified

8.92

57.08

1.3

1.1

—

Valvular operations

21.99

47.24

1.3

1.4

—

General symptoms and signs

101

6.50

45.01

1.1

1.2

—

Valvular heart disease excluding rheumatic fever

8.18

37.14

1.3

1.2

—

Non-rheumatic valve diseases

8.17

37.10

1.3

1.2

—

Endocarditis

+∞

36.63

1.3

0.0

—

Other bacterial diseases

128

4.70

33.40

1.2

1.1

—

Systemic connective tissue disorders

6.89

28.77

1.0

1.2

—

Atrial fibrillation and flutter

10.20

27.65

1.3

1.0

—

ILD medications

128

4.03

27.52

1.1

1.2

—

ILD medications: prednisolone, methylprednisolone, prednisone

126

4.04

26.73

1.2

—

Oral corticosteroids

136

3.87

25.21

1.2

1.1

—

Enlarged lymph nodes

13.57

24.50

1.1

—

Inflammatory bowel disease treatment related agents

141

3.67

23.99

1.2

1.1

—

Other heart diseases

5.80

23.42

1.2

1.0

—

Other necrotizing vasculopathies

15.49

22.80

1.0

1.5

—

Pneumonias (Asthma/COPD co-morbidities)

151

3.67

22.73

1.2

1.1

—

Pneumonia, organism unspecified

140

3.83

22.56

1.2

1.1

—

GASTRO-related operations

5.19

22.23

1.2

1.0

—

Any gastric operation

5.19

22.23

1.2

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

153

3.63

22.20

1.2

1.1

—

All pneumoniae

153

3.61

22.18

1.2

1.1

—

Influenza and pneumonia

151

3.57

22.03

1.2

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

115

3.82

20.26

1.2

—

115

3.82

20.26

1.2

—

ILD medications: immunosuppressive drugs

111

4.32

19.63

1.0

1.1

—

Certain infectious and parasitic diseases

4.06

19.41

1.2

1.1

—

Presence of cardiac and vascular implants and grafts

4.91

19.33

1.3

1.2

—

Malaise and fatigue

6.17

18.69

1.3

1.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

154

3.35

18.23

1.2

1.1

—

Other heart diseases, wide

117

3.61

18.22

1.2

1.1

—

First line medication for Crohn's disease

132

3.31

18.08

1.2

—

Autoimmune diseases related-to ILD

163

3.46

18.02

1.1

—

Bacterial Sepsis

4.63

16.69

1.5

1.1

—

Other systemic involvement of connective tissue (FG)

6.72

15.97

1.0

1.1

—

Pacemaker

5.76

15.85

1.1

1.3

—

Atrial fibrillation and flutter with reimbursement

8.45

15.59

1.4

1.0

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

10.68

15.54

1.2

1.0

—

Headache

4.61

15.46

1.2

1.1

—

Infections, IBD-co-morbidities

10.66

14.71

1.1

—

Cardiac arrhythmias

3.89

14.31

1.2

1.1

—

Implicit bacterial Sepsis

4.52

13.98

1.6

1.1

—

Other systemic involvement of connective tissue

5.69

13.65

1.0

1.3

—

Dialysis, with operation codes

6.92

13.13

1.3

—

Septicaemia

4.81

13.04

1.3

1.1

—

COPD/asthma/ILD related infections

115

2.96

12.71

1.2

—

COPD/asthma related infections

115

2.96

12.71

1.2

—

Nephropathy related operations

7.06

12.69

1.3

—

Heart failure, not strict

104

3.32

12.43

1.2

1.1

—

Continuous positive airway pressure

7.77

12.24

1.7

1.0

—

Other and unspecified anaemias

4.19

12.19

1.1

1.2

—

Other anaemias

4.18

12.14

1.1

1.2

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

7.53

12.08

1.0

1.4

—

Other septicaemia

4.81

11.34

1.4

1.1

—

Implicit Sepsis

126

3.02

10.96

1.4

1.1

—

Abnormalities of breathing

117

2.90

10.94

1.2

1.1

—

Heart failure,strict

3.66

10.80

1.3

1.2

—

Aplastic and other anaemias

3.73

10.73

1.1

1.2

—

Other necrotizing vasculopathies (FG)

17.89

10.72

1.0

—

Dyspnoea

156

2.75

10.58

1.2

1.1

—

Adjustment and management of implanted device

6.01

10.38

1.4

1.1

—

Aortic valve malfunction, age under 60 years

6.32

10.27

1.5

1.0

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

6.09

9.92

1.5

1.0

—

Cardiodefibrillation

3.83

9.62

1.1

1.2

—

Pain in throat and chest

110

2.83

9.57

1.3

1.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

153

2.58

9.43

1.2

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

140

2.70

9.40

1.4

1.1

—

Heart failure and antihypertensive medication

5.20

9.38

1.5

1.0

—

Implicit viral Sepsis

5.30

9.15

1.5

1.1

—

Viral Sepsis

5.15

8.87

1.5

1.1

—

Second line medication for Crohn's disease

128

2.97

8.84

1.0

1.1

—

Heart failure, strict

3.17

8.81

1.3

1.2

—

L04AX Other immunosuppressants

123

3.01

8.80

1.0

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

3.08

8.68

1.1

1.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

148

2.41

8.64

1.1

1.2

—

Other pulmonary diagnosis

2.86

8.62

1.2

—

Anaemias

5.50

8.59

1.0

—

Calcific aortic valvular stenosis

4.23

8.56

1.4

1.2

—

Calcific aortic valvular stenosis, operated

4.23

8.56

1.4

1.2

—

Calcific aortic valvular stenosis, diagnosis (helper)

4.23

8.56

1.4

1.2

—

Operations 2 for CAVS

4.23

8.56

1.4

1.2

—

Polymyalgia rheumatica

7.52

8.41

1.1

1.4

—

Autoimmune diseases excluding thyroid diseases

153

2.36

8.38

1.1

1.2

—

Calcific aortic valvular stenosis, including rheumatic fever

4.14

8.35

1.4

1.2

—

Asthma, unspecified (mode), excluding more controls

3.50

8.25

1.3

1.2

—

Explicit Sepsis

3.35

8.15

1.3

1.1

—

Giant cell arteritis

22.15

8.02

1.0

—

Bacterial pneumonia (organism specified)

3.17

7.91

1.3

1.1

—

Excluding asthma or asthma-COPD overlap

2.74

7.72

1.2

—

COPD differential diagnosis

2.74

7.72

1.2

—

ILD differential diagnosis

2.74

7.72

1.2

—

Renal failure

3.33

7.70

1.4

1.2

—

Abnormal findings on examination of blood, without diagnosis

3.03

7.61

1.5

1.1

—

Other infectious diseases

6.69

7.60

1.0

1.4

—

Fibromyalgia

7.35

7.55

1.1

1.0

—

Bacterial pneumoniae

3.44

7.46

1.3

1.2

—

Other respiratory diseases principally affecting the interstitium

5.18

7.44

1.8

1.1

—

Renal tubulo-interstitial diseases

159

2.41

7.41

1.4

1.1

—

Other arthritis (FG)

3.73

7.33

1.4

1.1

—

Covid-19 confirmed case

3.73

7.33

1.0

1.1

—

Other diseases of arteries and capillaries

6.33

7.24

1.0

1.4

—

Asthma, unspecified (mode)

3.19

7.23

1.3

1.2

—

All influenza

4.29

7.20

1.6

1.1

—

Symptoms and signs involving the circulatory and respiratory systems

119

2.36

7.08

1.2

1.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

4.05

7.06

1.1

1.2

—

Cerebrovascular diseases (FINNGEN)

4.60

7.01

1.2

1.0

—

Acute upper respiratory infections of multiple and unspecified sites

137

2.46

6.95

1.2

1.1

—

Heart failure and bmi 25plus

3.89

6.94

1.4

1.2

—

Care involving dialysis

6.49

6.77

1.5

1.0

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

12.64

6.72

1.4

1.1

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

132

2.60

6.70

1.1

1.2

—

Other diseases of pleura

3.11

6.66

1.2

—

Paroxysmal tachycardia

4.88

6.61

1.6

1.0

—

Diseases of arteries, arterioles and capillaries

109

2.60

6.57

1.4

1.1

—

Syncope and collapse

3.92

6.56

1.0

1.2

—

Accidents

105

2.39

6.50

1.2

1.1

—

Acute renal failure

4.33

6.48

1.6

1.3

—

Other specified/unspecified arthritis

3.64

6.46

1.5

1.1

—

Pain in joint

2.73

6.40

1.0

1.1

—

Hypertensive diseases (excluding secondary)

3.12

6.38

1.4

1.0

—

Bacterial pneumonia, not elsewhere classified

3.34

6.35

1.4

1.2

—

Finngen Rheumatological endpoints

134

2.26

6.35

1.2

—

Rickettsioses

+∞

6.35

4.3

0.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

3.73

6.34

1.1

1.3

—

Certain disorders involving the immune mechanism

4.05

6.34

1.6

1.1

—

Unspecified kidney failure

6.68

6.31

1.2

1.5

—

ILD, hospital admissions 1, main diag only

5.47

6.28

1.4

—

Heart failure and hypertrophic cardiomyopathy

+∞

6.26

2.2

0.0

—

AV-block

5.45

6.07

1.1

1.4

—

Viral pneumonia

5.23

6.00

1.2

1.1

—

Other bacterial intestinal infections

4.52

5.97

1.1

—

Cardiomyopathy

4.82

5.96

1.7

1.2

—

Dentinal caries

3.85

5.93

1.2

1.1

—

Metabolic disorders

141

2.20

5.84

1.2

1.1

—

Enterocolitis due to Clostridium difficile

5.51

5.80

1.2

1.4

—

Other external causes of accidental injury

105

2.29

5.76

1.2

1.1

—

All-cause Heart Failure

2.69

5.70

1.1

1.2

—

Autoimmune diseases

156

2.03

5.63

1.1

1.2

—

Extracorporeal dialysis

5.90

5.63

1.5

1.4

—

ILD, hospital admission 2, with pulmonary infections

5.90

5.62

1.0

1.1

—

Hypothyroidism, drug reimbursement

6.05

5.58

1.0

—

Other arrhythmias

2.64

5.58

1.0

1.1

—

Q fever

+∞

5.53

4.6

0.0

—

Other disorders of fluid, electrolyte and acid-base balance

3.40

5.52

1.4

1.1

—

Examination and observation for other reasons

2.55

5.42

1.3

1.1

—

Giant cell arteritis with polymyalgia rheumatica

16.09

5.41

1.0

—

Other or ill-defined heart diseases

16.05

5.41

1.1

1.0

—

Disorders of thyroid, IBD co-morbidities

5.73

5.37

1.2

1.1

—

Bacterial intestinal infections, IBD co-morbidities

4.12

5.35

1.1

1.3

—

Other interstitial pulmonary diseases

4.62

5.25

1.4

1.1

—

Factors influencing health status and contact with health services

3.51

5.22

1.4

1.1

—

Cardiomyopathy, Hypertrophic obstructive

+∞

5.21

2.4

0.0

—

General examination and investigation of persons without complaint and reported diagnosis

2.43

5.17

1.1

—

Depression medications

3.36

5.15

1.1

—

Asthma, excluding more controls

2.49

5.12

1.3

1.2

—

Conduction disorders

3.70

5.05

1.6

1.2

—

ILD, hospital admissions

4.45

5.03

1.4

1.3

—

Interstitial lung disease endpoints

4.45

5.03

1.4

1.3

—

Interstitial lung disease

4.45

5.03

1.4

1.3

—

Diarrhoea and gastroenteritis of presumed infectious origin

155

2.23

5.01

1.2

1.1

—

Persons encountering health services for specific procedures and health care

176

1.97

4.99

1.2

1.1

—

Intestinal infectious diseases

188

2.03

4.96

1.2

1.1

—

Disorders of lipoprotein metabolism and other lipidaemias

116

2.22

4.96

1.0

1.1

—

Complications of medical and surgical care

158

2.22

4.90

1.1

1.2

—

Asthma

2.36

4.90

1.3

1.2

—

Disorders of eyelid, lacrimal system and orbit

159

2.12

4.90

1.1

1.2

—

Haemorrhage from respiratory passages

3.15

4.90

1.4

1.2

—

Used for control exclusion in common control thyroid runs

146

1.98

4.89

1.1

1.2

—

Acute bronchitis

2.70

4.83

1.4

1.1

—

Pain, not elsewhere classified

4.29

4.82

1.2

1.0

—

Dental caries

3.30

4.79

1.2

1.1

—

Chronic kidney disease

3.15

4.71

1.3

1.2

—

Pain (limb, back, neck, head abdominally)

2.25

4.70

1.2

1.1

—

Codes for special purposes

114

2.46

4.69

1.3

1.1

—

Provisional assignment of new diseases of uncertain etiology

114

2.46

4.69

1.3

1.1

—

Asthma-related pneumonia

2.78

4.69

1.5

1.1

—

Asthma-related pneumonia or sepsis

2.78

4.69

1.5

1.1

—

Asthma, hospital admissions 3, pneumonia

2.78

4.69

1.5

1.1

—

Asthma (only as main-diagnosis), excluding more controls

2.46

4.62

1.4

1.2

—

Bronchitis

179

1.94

4.62

1.2

1.1

—

Symptoms and signs involving the skin and subcutaneous tissue

158

2.21

4.61

1.1

—

Reimbursement for rheumatic diseases

127

2.36

4.60

1.0

1.2

—

Early onset COPD, excluding more controls

3.82

4.52

1.8

1.1

—

Other specific joint derangements/joint disorders

126

2.13

4.47

1.1

1.2

—

Diseases of pulp and periapical tissues

2.77

4.43

1.4

1.1

—

ILD medications: azathioprine

4.01

4.43

1.1

1.0

—

Glomerular disorders in diseases classified elsewhere

4.24

4.35

1.0

1.3

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

7.52

4.35

1.3

1.6

—

Diseases of oesophagus, stomach and duodenum

173

1.90

4.34

1.4

1.1

—

Chronic periapical parodontitis

3.50

4.32

1.1

—

Exposure to unspecified factor

198

1.92

4.31

1.2

1.1

—

Ulcer of lower limb, not elsewhere classified

4.55

4.30

1.0

1.4

—

157

1.88

4.28

1.2

—

Bicuspidal aortic valve syndrome

11.72

4.28

1.0

—

Cardiovascular diseases

2.31

4.21

1.1

—

Dorsalgia

144

1.92

4.14

1.3

1.1

—

Any reimbursement code in KELA

2.27

4.11

1.1

—

Polyarthropathies

112

2.14

4.11

1.3

1.2

—

Other dorsopathies, not elsewhere classified

148

1.89

4.10

1.3

1.1

—

Pleural effusion

4.35

4.08

1.3

—

Azathioprine

3.75

4.08

1.1

1.0

—

Acute upper respiratory infections

170

1.88

4.05

1.2

1.1

—

Other diseases of blood and blood-forming organs, wide

3.19

4.05

1.1

1.2

—

Glomerular diseases

3.52

4.04

1.0

1.3

—

ILD, hospital admissions 3, with pneumonia sepsis

6.44

3.98

1.0

—

Diseases of liver

2.59

3.96

1.0

1.2

—

Other special examinations and investigations of persons without complaint or reported diagnosis

2.19

3.91

1.3

1.1

—

Non-ischemic cardiomyopathy

2.97

3.90

1.1

—

Diseases of the musculoskeletal system and connective tissue

2.32

3.80

1.3

1.2

—

Asthma (only as main-diagnosis)

2.23

3.80

1.4

1.2

—

Other viral diseases

2.59

3.77

1.0

1.2

—

Congenital malformations of aortic and mitral valves

8.78

3.77

1.0

—

Other specified/unspecified systemic involvement of connective tissue

8.77

3.77

1.0

—

SLE (Finngen)

12.04

3.76

1.0

—

Systemic lupus erythematosus

12.04

3.76

1.0

—

Ischaemic heart disease, wide definition

113

2.05

3.75

1.3

1.1

—

Neurological diseases, wide definition

3.16

3.71

1.0

1.1

—

Other soft tissue disorders, not elsewhere classified

151

1.88

3.69

1.3

1.1

—

Diseases of the skin and subcutaneous tissue

142

1.84

3.69

1.2

—

Disturbances of skin sensation

2.79

3.68

1.2

1.1

—

Mixed connective tissue disease

6.68

3.67

1.0

—

Cardiomyopathies, Primary/intrinsic

6.67

3.67

1.9

1.5

—

Candidiasis

3.67

3.63

1.3

—

Gastrointestinal diseases

2.22

3.60

1.4

1.0

—

Diseases of the respiratory system

2.22

3.60

1.3

1.2

—

Endocrine, nutritional and metabolic diseases

120

1.91

3.59

1.2

1.1

—

External causes of morbidity and mortality

2.13

3.59

1.4

1.1

—

Arthropathies

131

1.87

3.59

1.2

—

Pure hypercholesterolaemia

106

2.09

3.58

1.1

1.2

—

Dorsopathies

150

1.80

3.58

1.2

1.1

—

Left ventricular outflow tract obstruction, narrow definition

7.80

3.56

1.0

—

Sicca syndrome [Sjögren]

7.79

3.56

1.0

—

Hard cardiovascular diseases

119

2.00

3.54

1.4

1.1

—

Parasetamol

107

1.96

3.51

1.2

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

137

2.11

3.50

1.1

1.2

—

Pneumonia due to other infectious organisms, not elsewhere classified

10.04

3.50

1.0

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

3.85

3.48

1.0

—

Nutritional anaemias

103

2.27

3.43

1.0

1.2

—

Lower back pain or/and sciatica

186

1.79

3.41

1.3

1.1

—

Mycoses

2.76

3.41

1.2

—

Hypertrophic cardiomyopathy

7.03

3.36

2.0

1.0

—

Ischemic heart diseases

114

1.98

3.36

1.3

1.1

—

Asthma (mode)

2.09

3.34

1.3

1.2

—

Other inflammatory liver diseases

5.73

3.34

1.0

—

Zoster [herpes zoster]

3.44

3.33

1.0

1.3

—

Low back pain

138

1.95

3.31

1.4

1.1

—

Cardiomyopathy, other and unspecified

8.58

3.26

2.5

1.1

—

Streptococcal septicaemia

8.58

3.26

1.0

—

Asthma, hospital admission 2, infections

140

2.04

3.22

1.4

1.1

—

Asthma-related infections

140

2.04

3.22

1.4

1.1

—

Anxiety disorders, excluding more controls

147

1.85

3.22

1.3

1.1

—

Persons encountering health services for examination and investigation

2.04

3.18

1.3

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.49

3.17

1.2

1.0

—

Congenital malformations of the circulatory system

3.15

3.16

1.0

1.2

—

Complications of surgical and medical care, not elsewhere classified

177

1.78

3.13

1.2

—

Venous thromboembolism

114

2.13

3.10

1.6

1.1

—

Iron deficiency anaemia

2.29

3.09

1.0

1.2

—

Disorders of lacrimal system

2.28

3.09

1.1

1.2

—

STROKE

2.15

3.08

1.2

1.1

—

Other disorders of teeth and supporting structures

3.08

1.0

1.1

—

Osteoporosis

3.09

3.07

1.8

1.1

—

Constipation

152

1.84

3.06

1.5

1.1

—

Visual disturbances and blindness

112

2.14

3.05

1.2

1.1

—

Cardiomyopathy (excluding other)

5.01

3.05

1.9

1.4

—

Medical observation and evaluation for suspected diseases and conditions

2.02

3.04

1.1

—

Noninfective enteritis and colitis

112

2.14

3.04

1.0

1.1

—

Neurological diseases

130

1.78

3.03

1.3

1.1

—

Congenital malformations of heart and great arteries

3.23

3.02

1.0

1.3

—

Early onset COPD

2.89

3.02

1.8

1.1

—

Bleeding

145

1.86

3.01

1.4

1.1

—

Other disorders of skin and subcutaneous tissue

140

1.96

3.00

1.1

—

Myocardial infarction, without ST-elevation

2.37

2.99

1.5

1.1

—

Systemic lupus erythematosus, unspecified

10.04

2.98

1.0

—

Cerebrovascular diseases

123

1.92

2.97

1.2

—

Other disorders of lacrimal gland

2.40

2.96

1.1

1.2

—

Congenital malformations, deformations and chromosomal abnormalities

141

1.97

2.95

1.1

—

Other diseases of intestines

171

1.70

2.93

1.3

1.1

—

Adverse effects, not elsewhere classified

2.83

2.91

1.3

1.2

—

Allergic contact dermatitis

3.34

2.90

1.1

1.3

—

All influenza (not pneumonia)

3.34

2.90

1.1

—

107

2.13

2.90

1.5

1.1

—

Complications of procedures, not elsewhere classified

171

1.82

2.86

1.2

—

COPD, hospital admission 2, with asthma infections

2.53

2.83

1.7

1.2

—

Other acute lower respiratory infections

123

2.02

2.83

1.4

1.1

—

Other and unspecified dermatitis

116

2.07

2.81

1.0

1.2

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

2.71

2.81

1.8

1.2

—

Spondyloarthritis

3.06

2.80

1.5

1.3

—

Anxiety disorders

171

1.74

2.80

1.3

1.1

—

Other viral diseases, not elsewhere classified

2.76

2.79

1.0

1.2

—

Abdominal and pelvic pain

145

1.70

2.78

1.3

1.1

—

SLE, ICD10

8.36

2.75

1.0

—

SLE, strict definition

8.36

2.75

1.0

—

Abnormal findings on diagnostic imaging of lung

101

2.12

2.74

1.0

1.3

—

Symptoms and signs involving the nervous and musculoskeletal systems

131

1.98

2.73

1.1

1.2

—

Chronic rhinitis, nasopharyngitis and pharyngitis

2.36

2.71

1.1

—

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

6.02

2.70

1.5

1.7

—

Antihypertensive medication - note that there are other indications

1.95

2.68

1.1

1.0

—

Benign neoplasm: Caecum

4.22

2.67

2.1

1.4

—

Benign neoplasm: Caecum

4.22

2.67

2.1

1.4

—

Explicit bacterial Sepsis

4.22

2.67

1.0

—

Episodal and paroxysmal disorders

162

1.65

2.66

1.3

1.1

—

Falls/tendency to fall

166

1.63

2.65

1.2

1.1

—

Gastro-oesophageal reflux disease

148

1.86

2.65

1.1

—

Other symptoms and signs involving the nervous and musculoskeletal systems

2.12

2.63

1.0

1.1

—

Persons encountering health services in other circumstances, wide

177

1.61

2.62

1.2

1.1

—

Oedema, not elsewhere classified

3.11

2.62

1.0

1.1

—

Direct fill therapy

2.90

2.57

1.3

1.2

—

Amputation

4.00

2.56

1.0

1.4

—

Hepatic failure, not elsewhere classified

7.17

2.55

1.0

—

Other and unspecified effects of external causes

2.35

2.55

1.3

1.2

—

Sciatica+with lumbago

108

2.02

2.54

1.4

1.1

—

Other neurological diseases

136

1.83

2.52

1.1

1.2

—

Injury, poisoning and certain other consequences of external causes

1.99

2.49

1.4

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

176

1.62

2.49

1.2

1.1

—

Other pleural conditions

4.38

2.47

1.0

1.4

—

Hypothyroidism (congenital or acquired)

2.77

2.46

1.2

1.0

—

Peripheral artery operations in Hilmo

3.81

2.46

1.0

1.4

—

Opioids

154

1.64

2.45

1.3

1.1

—

Subjective visual disturbances

2.55

2.44

1.0

1.2

—

Neoplasms

125

1.72

2.43

1.2

1.1

—

Other diseases of the respiratory system

2.94

2.41

1.3

—

Other respiratory disorders and diseases

2.94

2.41

1.3

—

Need for other prophylactic measures

5.01

2.40

1.0

—

Dermatitis and eczema

196

1.61

2.39

1.0

1.2

—

Oxycodone

2.22

2.38

1.5

1.1

—

Secondary hypertension

4.96

2.38

1.0

—

Hypo-osmolality and hyponatraemia

3.33

2.38

1.9

1.1

—

Other disorders involving the immune mechanism, not elsewhere classified

6.27

2.37

2.4

1.0

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

6.27

2.37

1.0

—

Recurring oral aphthae

6.26

2.37

1.2

1.0

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

3.64

2.36

1.0

1.4

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

132

1.89

2.34

1.1

1.2

—

Non-selective monoamine reuptake inhibitors

2.20

2.33

1.1

—

Hypertension, essential

114

1.75

2.32

1.4

1.0

—

Neurotic, stress-related and somatoform disorders

171

1.66

2.32

1.3

1.1

—

Symptoms and signs involving the digestive system and abdomen

145

1.62

2.32

1.3

1.1

—

Transport accidents

2.06

2.32

1.2

1.1

—

Other inflammation of eyelid

3.22

2.30

1.0

1.3

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

2.13

2.30

1.4

1.1

—

Crohn disease

2.86

2.30

1.0

1.2

—

Acute sinusitis

104

1.97

2.29

1.4

1.1

—

Hypertensive diseases

118

1.73

2.28

1.3

1.0

—

Hypertension

118

1.73

2.28

1.3

1.0

—

Care involving use of rehabilitation procedures

140

1.83

2.28

1.1

—

Other disorders of white blood cells

4.63

2.27

1.0

1.5

—

Melanocytic naevi of trunk

3.48

2.27

1.0

1.3

—

Sleep disorders (combined)

174

1.62

2.24

1.3

1.1

—

Other disorders of urethra and urinary system

121

1.80

2.22

1.3

1.1

—

Urticaria and erythema

2.09

2.22

1.2

—

Asthma (diagnoses ohter than nonallergic)

191

1.66

2.20

1.3

1.1

—

Somatoform disorder

2.78

2.20

1.7

1.1

—

Visual disturbances

107

1.96

2.19

1.2

1.1

—

Phobic anxiety disorders

3.33

2.17

1.3

1.1

—

Erysipelas

2.04

2.16

1.2

1.1

—

Selective serotonin reuptake inhibitors

152

1.59

2.15

1.1

1.2

—

Secondary and unspecified malignant neoplasm of lymph nodes

3.69

2.15

1.0

1.4

—

Collagenous colitis

3.69

2.15

1.0

1.1

—

Sarcoidosis

3.00

2.14

1.3

1.1

—

Pain in thoracic spine

3.00

2.14

1.8

1.0

—

Vocal cord dysfunction

4.29

2.13

1.3

1.0

—

Cough

2.16

2.12

1.1

—

Injuries to the neck

2.37

2.11

1.7

1.1

—

Other spirochaetal diseases

2.37

2.11

1.1

1.3

—

Persons with potential health hazards related to communicable diseases

101

1.96

2.10

1.2

1.1

—

Abnormal findings on diagnostic imaging of other body structures

3.20

2.09

1.1

1.3

—

Diseases of the eye and adnexa

122

1.64

2.09

1.3

1.1

—

Disorders of sclera, cornea, iris and ciliary body

138

1.81

2.08

1.2

—

Osteopathies and chondropathies

117

1.86

2.07

1.5

1.1

—

Cerebral cysts

5.01

2.07

1.0

—

Other and unspecified iron deficiency

2.26

2.07

1.0

1.2

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2.54

2.04

1.0

1.2

—

Ischaemic Stroke, excluding all haemorrhages

1.85

2.04

1.2

1.3

—

Amputation of toe

4.01

2.04

1.0

1.5

—

Convulsions, not elsewhere classified

2.87

2.04

1.0

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

181

1.59

2.02

1.3

1.1

—

Anterior Iridocyclitis

2.40

2.02

1.4

1.2

—

Disorders of muscles

3.08

2.01

1.1

1.0

—

Myocardial infarction

1.90

2.01

1.5

1.1

—

Symptoms and signs involving the urinary system

147

1.68

2.01

1.3

1.2

—

Intracranial trauma

103

1.81

2.00

1.4

1.1

—

Concussion

102

1.87

1.97

1.4

1.1

—

Abnormalities of heart beat

2.20

1.96

1.6

1.1

—

Disorders of vestibular function (Vertigo)

1.95

1.96

1.1

1.2

—

Abnormal findings on diagnostic imaging of central nervous system

4.56

1.94

1.0

—

Crohn disease (strict definition, all UC cases excluded)

4.55

1.94

1.0

—

Aortic aneurysm

2.46

1.94

2.0

1.3

—

Other antidepressants

151

1.55

1.93

1.1

1.2

—

Osteomyelitis

3.76

1.93

1.0

—

Iron deficiency anaemia secondary to blood loss (chronic)

2.97

1.93

1.0

1.3

—

Abdominal aortic aneurysm (AAA)

4.51

1.92

3.0

1.6

—

Tramadol

133

1.64

1.90

1.4

1.1

—

Follow-up examination after treatment for conditions other than malignant neoplasms

1.98

1.89

1.2

1.1

—

Disorders of gallbladder, biliary tract and pancreas

164

1.57

1.88

1.3

1.1

—

Dermatitis

143

1.75

1.88

1.0

1.2

—

Hyperlipidaemia, other/unspecified

2.05

1.87

1.4

1.2

—

Iridocyclitis

2.31

1.87

1.4

1.2

—

Inflammatory bowel disease

2.03

1.85

1.1

—

Non-allergic asthma (mode), excluding more controls

2.83

1.84

1.1

—

Other Crohn's disease

3.53

1.83

1.0

—

Spermatocele

3.53

1.83

1.0

1.1

—

Deep endometriosis

3.53

1.83

1.0

1.2

—

Viral pneumonia (unknown virus, not influenza)

4.17

1.82

1.0

—

Depression

183

1.54

1.82

1.1

—

Haemorrhoids and perianal venous thrombosis

2.12

1.81

1.4

1.2

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.05

1.80

1.0

1.3

—

Secondary uncertain malignant neoplasm

3.05

1.80

1.0

1.4

—

Melanocytic naevi of trunk

2.76

1.79

1.0

1.3

—

Insulin, intermediate and long-acting

136

1.73

1.75

1.1

1.2

—

Spirochaetal infections, other/unspecified

3.34

1.74

1.0

1.4

—

Retinal vascular occlusion

3.34

1.74

1.3

1.4

—

Hypokalaemia

3.34

1.74

1.0

1.1

—

Retinal vascular disorders

3.34

1.74

1.3

1.4

—

Undetermined asthma, excluding more controls

3.33

1.74

2.2

1.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

142

1.69

1.73

1.1

1.2

—

Spondylopathies (FG)

2.67

1.72

1.0

1.1

—

Temporomandibular joint disorders

2.92

1.72

1.0

1.1

—

Lesion of lateral popliteal nerve

3.85

1.71

1.0

1.5

—

Other and unspecified mood [affective] disorders

3.85

1.71

1.0

—

Acute and subacute iridocyclitis

2.29

1.70

1.5

1.2

—

Diseases of oral cavity, salivary glands and jaws

129

1.55

1.69

1.3

1.2

—

Acute tubulo-interstitial nephritis

124

1.72

1.69

1.4

1.1

—

Stroke, excluding SAH

103

1.73

1.68

1.2

—

Personal history of other diseases and conditions

3.15

1.65

1.0

1.1

—

Congenital malformations of genital organs

3.14

1.65

1.3

1.0

—

Pulmonary heart disease, diseases of pulmonary circulation

2.10

1.65

1.5

1.2

—

Sequelae of cerebrovascular disease

2.05

1.64

1.1

1.3

—

Type 2 diabetes, wide definition

136

1.58

1.63

1.3

1.1

—

Cellulitis

2.25

1.63

1.2

—

Other gastritis (incl. Duodenitis)

2.25

1.63

1.5

1.0

—

Superficial injury of lower leg

2.25

1.63

1.2

1.1

—

Injuries to the thorax

105

1.81

1.62

1.9

1.1

—

Lyme disease

2.14

1.60

1.1

1.3

—

IBD patients in KELA-register

2.14

1.60

1.0

1.2

—

Other noninfective gastroenteritis and colitis

2.14

1.60

1.0

1.2

—

Non-invasive ventilation

2.51

1.59

1.9

1.0

—

Urticaria

1.95

1.58

1.2

1.1

—

Hypothyroidism, levothyroxine purchases

2.34

1.58

1.2

1.0

—

Hypothyroidism and >3 levothyroxin purchases

2.34

1.58

1.2

1.0

—

Benign neoplasm: Ascending colon

3.00

1.58

1.5

1.4

—

Peripheral arterial reconstruction

2.69

1.58

1.0

1.3

—

Dizziness and giddiness

147

1.60

1.57

1.4

1.1

—

Non-allergic asthma (mode)

2.48

1.57

1.1

—

Inflammatory bowel disease, strict (require KELA)

2.11

1.54

1.0

1.2

—

Diagnoses used for exclusion with ILD

2.11

1.54

1.3

1.2

—

Sleep apnoea

166

1.51

1.54

1.3

1.1

—

Localized swelling, mass and lump of skin and subcutaneous tissue

2.03

1.53

1.1

1.2

—

Other diseases of lip and oral mucosa

2.43

1.53

1.1

—

Spondylolisthesis/Spondylolysis

2.43

1.53

1.0

1.1

—

Pain and other conditions associated with female genital organs and menstrual cycle

2.28

1.53

1.0

1.1

—

Injuries to the head

202

1.45

1.53

1.2

1.1

—

Dental operations

1.62

1.51

1.3

1.2

—

Insulin medication

137

1.62

1.51

1.1

1.2

—

Soft tissue disorders

156

1.47

1.51

1.3

1.1

—

Disorder of lipoprotein metabolism, unspecified

2.86

1.50

1.0

1.1

—

Undetermined asthma

2.86

1.50

2.2

1.0

—

Persons encountering health services in other circumstances

1.86

1.49

1.0

1.1

—

Major coronary heart disease event excluding revascularizations

110

1.63

1.49

1.5

1.1

—

Colonic or urogenital fistula

2.00

1.48

1.8

1.2

—

Atopic dermatitis, strict definition with reimbursement

1.85

1.46

1.1

—

Peripheral artery disease

1.87

1.46

1.5

1.2

—

Nonorganic sleeping disorders, excluding more controls

2.22

1.46

1.0

—

Atherosclerosis, excluding cerebral and coronary sclerosis

1.90

1.44

1.4

1.2

—

Obesity related asthma

1.88

1.44

1.2

1.1

—

Otalgia

3.13

1.44

1.2

1.1

—

Emphysema

3.13

1.44

1.2

1.0

—

Other and unspecified vascular occlusions

3.13

1.44

1.4

1.5

—

Cholecystectomy

144

1.60

1.43

1.1

1.2

—

Disorders of optic nerve and visual pathways

2.73

1.43

1.2

1.4

—

Superficial injury of forearm

2.73

1.43

1.0

—

Pulmonary heart disease

2.03

1.43

1.5

1.2

—

Fracture of lumbar spine and pelvis

2.31

1.42

1.8

1.1

—

Fall on same level

194

1.41

1.42

1.2

1.1

—

Exposure to other specified factors

191

1.52

1.42

1.3

1.1

—

Sleep apnoea, including avohilmo

173

1.46

1.40

1.3

1.1

—

Depression or dysthymia

112

1.55

1.40

1.1

—

Chronic periodontitis

2.42

1.39

1.0

1.1

—

Nausea and vomiting

2.08

1.38

2.3

1.0

—

Other diseases of urinary system

159

1.45

1.38

1.3

1.2

—

Fissure and fistula of anal and rectal regions

2.00

1.37

1.4

1.0

—

Heart failure and coronary heart disease

1.98

1.37

1.7

1.1

—

Pulmonary embolism

2.00

1.37

1.5

1.2

—

COPD related to multimorbidity

1.86

1.37

1.6

1.1

—

Codeine

151

1.46

1.37

1.2

1.1

—

Missing teeth due to accident, extraction or parodontitis

2.61

1.36

1.0

1.1

—

Benign neoplasm: Ascending colon

2.61

1.36

1.5

1.3

—

Cholelithiasis, broad definition with cholecystitis

145

1.51

1.36

1.3

1.1

—

COPD

1.75

1.36

1.6

1.2

—

Suppurative and necrotic conditions of lower respiratory tract

2.95

1.36

1.0

1.4

—

Benign neoplasm: Transverse colon

2.94

1.36

1.4

1.5

—

Other complications of surgical and medical care, not elsewhere classified

2.94

1.36

1.4

—

Use of memantine

0.00

1.35

0.0

1.4

—

Use of other anti-dementia drugs

0.00

1.35

0.0

1.4

—

Pain in limb

142

1.53

1.35

1.5

1.1

—

Other and unspecified tonsillitis

1.84

1.35

1.1

—

Other headache syndromes

1.75

1.34

1.5

1.1

—

Cardiac murmurs and other cardiac sounds

2.91

1.34

1.0

—

Fracture at wrist and hand level

1.87

1.33

1.1

1.0

—

Insomnia

2.14

1.33

1.0

1.3

—

Cutaneous abscess, furuncle and carbuncle

1.97

1.32

1.0

1.2

—

Stroke, including SAH

111

1.60

1.32

1.2

—

Triptan medication for migraine, single purchase ok

139

1.51

1.31

1.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

139

1.51

1.31

1.1

—

Anxiety (asthma-related co-morbidities)

125

1.58

1.31

1.1

—

Mood [affective] disorders

195

1.42

1.30

1.1

1.2

—

Mood disorders

195

1.41

1.29

1.1

1.2

—

Tumor necrosis factor alpha inhibitors

2.35

1.29

1.0

1.1

—

Presence of other devices

2.35

1.29

1.0

1.2

—

Benign neoplasm of colon, rectum, anus and anal canal

1.65

1.28

1.5

1.2

—

Other reaction to severe stress, and adjustment disorders

1.76

1.28

1.1

—

Transient global amnesia

2.78

1.28

1.0

1.4

—

Ankylosing spondylitis

2.78

1.28

1.0

1.1

—

COPD-related respiratory insufficiency

2.78

1.28

3.0

1.0

—

Nonorganic sleeping disorders

2.08

1.27

1.0

1.2

—

Other joint disorders

131

1.46

1.27

1.1

1.2

—

COPD, hospital admissions

1.73

1.27

1.6

1.2

—

DVT of lower extremities and pulmonary embolism

1.75

1.27

1.4

1.2

—

Inflammatory diseases of prostate (prostatitis)

2.29

1.26

1.9

1.1

—

All anxiety disorders

129

1.56

1.26

1.1

—

Pregnancy with abortive outcome

1.61

1.26

1.1

—

Ovarian cyst

1.85

1.26

1.3

1.1

—

Injuries to the wrist and hand

205

1.41

1.26

1.3

1.1

—

Myocardial infarction, strict

1.71

1.25

1.5

1.1

—

Benign neoplasm: Colon

1.67

1.24

1.5

1.2

—

Other diseases of intestine

2.40

1.24

2.0

1.1

—

Atopic dermatitis, strict definition

1.77

1.23

1.0

1.1

—

Cholelithiasis

141

1.49

1.23

1.3

1.1

—

Fracture of rib(s), sternum and thoracic spine

1.91

1.22

2.4

1.1

—

COPD, early/later onset

1.71

1.22

1.6

1.2

—

Deforming dorsopathies

1.97

1.22

1.0

1.1

—

Sulfasalazine

2.04

1.21

1.0

1.1

—

Stomatitis and related lesions

2.63

1.21

1.2

1.1

—

Psoriatic and enteropathic arthropathies

2.63

1.21

1.0

1.1

—

Diseases of inner ear

121

1.62

1.21

1.1

1.2

—

Disorders of conjunctiva

177

1.47

1.21

1.1

—

Excessive, frequent and irregular menstruation

1.78

1.21

1.1

—

Other chronic obstructive pulmonary disease

1.70

1.20

1.6

1.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

169

1.43

1.20

1.2

1.1

—

Other nutritional deficiencies

160

1.53

1.20

1.1

—

Angina pectoris

1.60

1.20

1.5

1.1

—

Glomerulonephritis

2.31

1.18

1.0

1.3

—

Alzheimer’s disease, wide definition

0.00

1.17

0.0

1.3

—

Migraine

1.63

1.17

1.2

1.0

—

Mood disorders, excluding more controls

164

1.41

1.16

1.1

—

Obstructed labour due to maternal pelvic abnormality

0.00

1.16

0.0

1.1

—

Benign neoplasm: Colon

115

1.62

1.16

1.5

1.2

—

Coronary atherosclerosis

105

1.54

1.15

1.4

1.1

—

Memory loss

2.50

1.15

1.0

1.4

—

Nonalcoholic fatty liver disease

2.50

1.15

1.0

1.4

—

Benign neoplasm: Transverse colon

2.50

1.15

1.4

—

Other disorders of bladder

2.50

1.15

1.4

1.1

—

Transplanted organ and tissue status

2.50

1.15

1.0

1.1

—

Unspecified haematuria

1.67

1.15

1.0

1.2

—

COPD, hospital admissions 1, only main diagnosis

1.82

1.13

1.7

1.1

—

Special screening examination for infectious and parasitic diseases

2.02

1.13

1.1

—

Spondylopathies

119

1.48

1.13

1.2

1.1

—

Injuries to the knee and lower leg

194

1.36

1.12

1.2

1.1

—

Dental caries 3

125

1.43

1.12

1.3

1.2

—

2.33

1.12

1.0

—

Other diseases of liver

2.00

1.12

1.0

1.3

—

Codeine or tramadol medication

183

1.36

1.12

1.2

1.1

—

Acute pharyngitis

2.32

1.12

1.0

1.1

—

Dental caries 1 and operation codes

130

1.42

1.11

1.3

1.1

—

Diseases of the digestive system

103

1.65

1.11

1.8

1.1

—

Triptan medication for migraine, min. 3 purchases

112

1.55

1.10

1.1

—

Striking against or struck by other objects

1.78

1.10

1.0

1.2

—

Recurring oral aphthae, including avohilmo

2.26

1.10

1.1

1.2

—

Alcohol abuse, main dg, excluding more controls

2.26

1.10

1.0

1.1

—

Other and unspecified visual disturbances

2.38

1.09

1.4

1.3

—

Other shoulder lesions

2.38

1.09

1.0

—

Unspecified/other endometriosis

2.38

1.09

1.2

1.0

—

Hernia of abdominal wall, postoperative

2.38

1.09

1.0

—

Biological medication for rheuma

1.95

1.08

1.0

1.3

—

Noninfectious colitis NAS

2.19

1.08

1.0

1.3

—

Other disorders of the musculoskeletal system and connective tissue

2.19

1.08

1.1

1.3

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

2.19

1.08

1.0

1.3

—

Hydrocele

2.19

1.08

1.0

1.1

—

Nerve, nerve root and plexus disorders

183

1.37

1.07

1.1

1.2

—

Asthma, hospital admissions , main diagnosis only

195

1.42

1.07

1.4

1.1

—

Other diseases of upper respiratory tract

169

1.36

1.07

1.3

1.1

—

Polyarthrosis

2.17

1.07

1.0

1.1

—

Dental caries, including avohilmo

118

1.43

1.06

1.3

1.2

—

Dental caries 1

118

1.43

1.06

1.3

1.2

—

Disorders of other endocrine glands

103

1.62

1.06

1.2

—

Sequelae of external causes of morbidity and mortality

1.92

1.06

1.3

1.2

—

Blepharochalasis

1.92

1.06

1.1

1.3

—

Injuries to the hip and thigh

1.62

1.05

1.1

1.2

—

Other diseases of the digestive system

1.79

1.04

2.2

1.1

—

Carpal tunnel syndrome

133

0.54

1.04

1.1

1.2

—

Epilepsy

1.79

1.03

1.3

1.0

—

Ménière disease

2.27

1.03

1.0

1.4

—

Benign neoplasm: Colon, unspecified

1.95

1.03

1.9

1.3

—

Benign neoplasm: Sigmoid colon

2.06

1.02

1.4

1.3

—

Chronic lower respiratory diseases

196

1.32

1.02

1.3

1.1

—

Disorders of breast

100

0.46

1.01

1.0

1.1

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.69

1.01

1.0

1.2

—

Recurrent or chronic depression

1.62

1.00

1.1

—

Dysplasia of cervi uteri

1.88

1.00

1.0

1.1

—

Intracranial injury

134

1.51

1.00

1.4

1.1

—

Benign neoplasm: Sigmoid colon

2.00

1.00

1.4

1.3

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

136

1.51

0.99

1.1

—

Obesity

154

1.48

0.99

1.1

—

Mouth breathing

107

1.59

0.99

1.5

1.1

—

Obesity and other hyperalimentation

154

1.48

0.99

1.1

—

Other and unspecified urticaria

1.84

0.98

1.1

1.2

—

Endometriosis ASRM stages 3,4

1.84

0.98

1.0

1.1

—

Endometriosis

1.76

0.98

1.1

—

Functional dyspepsia

1.80

0.98

2.0

1.0

—

Injury of muscle and tendon at hip and thigh level

2.18

0.98

1.0

1.3

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2.18

0.98

1.0

1.4

—

Use of donepezil

0.00

0.97

0.0

1.3

—

Alzheimer’s disease (Late onset)

0.00

0.97

0.0

1.3

—

Superficial injury of abdomen, lower back and pelvis

1.95

0.97

1.0

1.1

—

Other (seronegative) rheumatoid arthritis, wide

1.95

0.97

1.0

1.2

—

Genitourinary diseases

1.46

0.96

1.3

1.1

—

Sleep disorders

1.85

0.96

1.0

1.2

—

Poor fetal growth

0.00

0.96

0.0

1.1

—

Contact with and exposure to communicable diseases

1.62

0.95

1.2

1.1

—

Benign neoplasm: Colon, unspecified

1.77

0.94

1.9

1.2

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

1.89

0.94

1.1

1.3

—

Exclusions for E4_PCOS_BROAD

1.89

0.94

1.4

1.2

—

Rheumatoid arthritis

1.73

0.94

1.0

1.2

—

Seropositive rheumatoid arthritis

1.89

0.93

1.0

1.1

—

Obesity due to excess calories

117

1.54

0.93

1.2

1.1

—

Internal derangement of knee

1.61

0.92

1.0

1.2

—

Unspecified privation

2.14

0.91

1.3

—

Dental pulpitis 2

105

1.41

0.91

1.3

1.1

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1.67

0.91

1.1

1.2

—

Injuries to the shoulder and upper arm

189

1.37

0.91

1.2

1.1

—

Atopic dermatitis

121

1.48

0.90

1.0

1.1

—

Use of hypnotics and sedatives

174

1.33

0.90

1.2

1.1

—

Other intervertebral disc disorders

132

1.39

0.90

1.3

1.1

—

Coxarthrosis [arthrosis of hip](FG)

1.59

0.89

1.0

1.3

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

0.48

0.89

1.0

1.1

—

L04AD Calcineurin inhibitors

2.07

0.89

1.0

1.3

—

Other disorders of conjunctiva

2.07

0.89

1.0

1.3

—

Hallux rigidus

2.07

0.89

1.0

1.1

—

Other and unspecified polyneuropathies, also in other diseases

1.91

0.88

1.0

1.2

—

Acute pancreatitis

1.91

0.88

1.0

—

Phlebitis and thrombophlebitis (not including DVT)

1.91

0.88

1.9

1.2

—

Benign neoplasm of colon, rectum, anus and anal canal

129

1.47

0.88

1.5

1.2

—

Other chronic obstructive pulmonary disease, including avohilmo

105

1.50

0.88

1.6

1.2

—

Diseases of the ear and mastoid process

179

1.30

0.88

1.2

1.1

—

Statin medication

107

1.42

0.87

1.4

1.0

—

L04AA Selective immunosuppressants

1.79

0.87

1.0

1.2

—

Bell's palsy

2.00

0.87

1.2

1.3

—

Other functional intestinal disorders

1.55

0.87

2.0

1.1

—

Misadventures to patients during surgical and medical care

1.94

0.84

1.2

1.3

—

Inflammatory disease of uterus

1.94

0.84

1.0

1.1

—

Other hammer toe(s) (acquired)

1.94

0.84

1.0

1.1

—

Major coronary heart disease event

118

1.41

0.84

1.5

1.1

—

Chronic periodontitis, including avohilmo

176

1.35

0.83

1.1

1.2

—

Acute pancreatitis (for exclusion)

1.74

0.82

1.0

1.2

—

COPD (mode)

1.76

0.82

1.2

1.3

—

Other disorders of eye and adnexa

1.88

0.81

1.2

—

Appendectomy

165

1.40

0.81

1.0

1.1

—

Infections of the skin and subcutaneous tissue

154

1.42

0.81

1.1

—

Parodontitis

176

1.34

0.81

1.1

1.2

—

Coxibs

1.62

0.81

1.1

1.3

—

Parodontitis or operation codes

176

1.34

0.81

1.1

1.2

—

Dental operations, only avohilmo

108

1.38

0.80

1.3

1.2

—

Endometriosis of pelvic peritoneum

1.85

0.80

1.0

1.1

—

Ulcerative colitis

1.72

0.79

1.1

1.2

—

Speech and linguistic disorders

0.00

0.79

0.0

1.0

—

Foreign body entering into or through eye or natural orifice

0.00

0.79

0.0

1.3

—

Open wound of forearm

0.00

0.79

0.0

1.0

—

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

0.00

0.79

0.0

1.3

—

Fall on same level involving ice and snow

139

1.44

0.79

1.2

—

Malignant neoplasm

152

1.33

0.78

1.0

1.2

—

Polyneuropathies and other disorders of the peripheral nervous system

1.67

0.78

1.0

1.2

—

Multiple delivery

0.00

0.78

0.0

1.2

—

Diseases of the myoneural junction and muscle

0.00

0.78

0.0

1.3

—

Benign mammary dysplasia

0.00

0.78

0.0

1.1

—

Pregnancy hypertension

0.52

0.78

1.0

1.1

—

Rheumatoid arthritis, including avohilmo

1.59

0.78

1.0

1.2

—

Paracetamol of NSAID medication

1.74

0.77

1.0

1.3

—

Other benign neoplasms of connective and other soft tissue

0.00

0.77

0.0

1.3

—

Infective dermatitis

0.00

0.77

0.0

1.3

—

Dental caries 3 and operation codes, only avohilmo

1.55

0.77

1.5

1.1

—

Dental pulpitis 2, only avohilmo

109

1.36

0.77

1.3

1.1

—

Dental caries 3 and operation codes

136

1.32

0.77

1.3

1.1

—

Benign neoplasms

168

1.30

0.76

1.1

—

Gingivitis and periodontal diseases

128

1.33

0.76

1.1

1.2

—

GI-bleeding

1.64

0.75

2.3

1.1

—

Glaucoma suspect

1.60

0.74

1.0

1.2

—

Inguinal hernia, bilateral

2.08

0.74

1.2

1.1

—

Inguinal or femoral hernia, bilateral

2.08

0.74

1.2

1.1

—

Monoamine oxidase A inhibitors

2.08

0.74

1.2

1.3

—

Myalgia

1.67

0.74

1.0

1.1

—

Paralytic ileus and intestinal obstruction

1.67

0.74

1.1

—

Dental caries 3, only avohilmo

132

1.32

0.74

1.3

1.2

—

Cystitis

132

1.34

0.74

1.3

1.1

—

Asthma, including avohilmo

202

1.27

0.73

1.3

1.1

—

Organic, including symptomatic, mental disorders

0.54

0.73

1.0

1.2

—

Ulcerative colitis, NAS

1.84

0.73

1.0

1.3

—

Diabetes, varying definitions

171

1.29

0.73

1.3

1.1

—

Methotrexate

2.00

0.72

1.0

—

Diseases of salivary glands

1.80

0.72

1.0

1.1

—

Focal epilepsy, strict definition

1.79

0.72

1.1

1.3

—

Conjunctivitis

168

1.35

0.72

1.1

—

Dental pulpitis 1

167

1.28

0.72

1.3

1.1

—

Benign paroxysmal vertigo

1.67

0.72

1.0

1.2

—

Diseases of pulp and periapical tissues, including avohilmo

167

1.28

0.72

1.3

1.1

—

Dental pulpitis 4

167

1.28

0.72

1.3

1.1

—

Obesity, other/unspecified

1.55

0.71

1.2

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1.62

0.71

1.6

1.2

—

Sequelae of injuries, of poisoning and of other consequences of external causes

1.58

0.71

1.2

—

Gout

1.58

0.71

1.0

1.3

—

Diabetes mellitus

172

1.28

0.70

1.3

1.1

—

Postpartum care and examination

1.72

0.70

1.3

1.0

—

Dislocation, sprain and strain of joints and ligaments at neck level

1.71

0.70

1.3

1.0

—

Unspecified fall

117

1.44

0.69

1.2

—

Parodontitis and operation codes

178

1.31

0.68

1.1

1.2

—

Gout, FINNGEN

1.53

0.68

1.0

1.2

—

Dental caries 1, only avohilmo

125

1.31

0.68

1.3

1.2

—

Benign neoplasms

129

1.32

0.67

1.1

—

Perineal laceration during delivery

1.64

0.67

1.1

1.0

—

Other anxiety disorders

105

1.44

0.67

1.1

—

Viral infections characterized by skin and mucous membrane lesions

102

1.47

0.67

1.0

1.2

—

Diabetic nephropathy, excluding more controls

1.81

0.67

1.0

1.6

—

Alcohol abuse, main dg

1.63

0.66

1.0

1.2

—

HSIL lesion of the cervix uteri

1.63

0.66

1.0

1.1

—

Sequelae with surgical and medical care as external cause

1.63

0.66

1.1

1.2

—

Coagulation defects, purpura and other haemorrhagic conditions

1.63

0.66

1.0

1.3

—

Fracture of skull and facial bones

1.63

0.66

1.3

1.1

—

Ankylosing spondylitis, ICD10

1.79

0.66

1.0

1.3

—

Injury of muscle and tendon at lower leg level

1.79

0.66

2.4

1.1

—

Other medical care

1.54

0.65

1.1

—

Diabetic nephropathy

1.76

0.65

1.0

1.3

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

162

1.28

0.65

1.3

1.1

—

Cervicobrachial syndrome

1.59

0.65

1.0

1.1

—

Type of accident

1.61

0.65

1.7

1.2

—

Complications of labour and delivery

0.64

1.2

1.1

—

Transient ischemic attack

1.42

0.64

1.1

1.3

—

Thoracic aortic aneurysm

1.72

0.64

1.2

1.3

—

Superficial injury of ankle and foot

1.72

0.64

1.4

1.0

—

Purpura and other haemorrhagic conditions

1.72

0.64

1.0

1.3

—

Atrophic disorders of skin

1.72

0.64

1.0

—

Other disorders of eyelid

1.50

0.63

1.1

1.2

—

Alzheimer’s disease (Late onset), excluding more controls

0.00

0.62

0.0

1.0

—

Nonsuppurative otitis media

1.60

0.62

1.7

1.1

—

Allergic conjunctivitis

136

1.38

0.61

1.1

—

Alzheimer’s disease, wide definition, excluding more controls

0.00

0.61

0.0

1.0

—

Intestinal stricture

1.59

0.61

1.6

1.2

—

Disorders of vitreous body

102

1.44

0.61

1.0

1.2

—

Migraine with aura and triptan purchases

1.67

0.61

1.0

1.1

—

Generalized anxiety disorder

1.67

0.61

1.0

1.1

—

Other symptoms and signs involving the digestive system and abdomen

1.67

0.61

1.6

1.0

—

Other/unspecified dorsalgia

1.51

0.61

1.8

1.1

—

Car occupant injured in other and unspecified transport accidents

1.60

0.61

1.0

1.2

—

Excessive attrition of teeth

1.49

0.61

1.0

1.1

—

Other symptoms and signs involving cognitive functions and awareness

1.46

0.61

1.1

—

Malignant neoplasm of head and neck

0.00

0.60

0.0

1.4

—

Other and unspecified myopathies

0.00

0.60

0.0

1.4

—

Carbimazole or st.post thyroidectomy, condition for graves disease

1.57

0.60

1.0

1.2

—

Dislocation, sprain and strain of joints and ligaments of knee

153

1.34

0.60

1.1

—

Diabetic retinopathy, excluding more controls

1.55

0.60

1.3

1.4

—

Synovial cyst of popliteal space [Baker]

0.00

0.60

0.0

1.0

—

Non-allergic asthma

0.00

0.60

0.0

1.4

—

Subarachnoid haemorrhage

0.00

0.60

0.0

1.4

—

Retinal detachments and breaks

1.50

0.59

1.2

—

Viral warts

0.00

0.59

0.0

1.3

—

Dementia in Alzheimer disease

0.00

0.59

0.0

1.4

—

Disorders of vitreous body and globe

103

1.42

0.58

1.0

1.2

—

Keratitis

1.46

0.57

1.0

1.2

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

107

1.37

0.57

1.1

1.2

—

Superficial injury of thorax

1.67

0.56

1.0

1.1

—

Unspecified acute lower respiratory infection

1.67

0.56

2.5

1.1

—

Gout, strict definition

1.67

0.56

1.0

1.3

—

Other blood glucose lowering drugs, excl. Insulins

1.67

0.56

1.3

—

DVT of lower extremities

1.67

0.56

1.0

1.3

—

Substance use, excluding alcohol

1.45

0.56

1.3

1.1

—

Diverticular disease of intestine

116

1.32

0.56

1.2

1.1

—

Assault

1.62

0.55

1.0

1.2

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1.62

0.55

1.0

1.1

—

Senile cataract

1.35

0.55

1.6

1.1

—

Psychiatric diseases

163

1.23

0.55

1.3

1.1

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.43

0.54

1.0

1.1

—

Polycystic ovarian syndrome, consortium definition

1.33

0.54

1.1

—

Disorders of lens

105

1.32

0.54

1.5

1.1

—

Glaucoma

109

1.37

0.54

1.1

1.2

—

Disorders of parathyroid gland

1.56

0.53

1.3

1.2

—

Gonarthrosis [arthrosis of knee](FG)

1.33

0.53

1.1

1.2

—

Mucosal proctocolitis

1.54

0.53

1.0

1.2

—

Cervicalgia

1.54

0.53

2.2

1.1

—

Diabetes, insulin treatment (Kela reimbursement)

168

1.24

0.52

1.3

1.1

—

Sensorineural hearing loss

130

1.29

0.52

1.3

1.2

—

Other diseases of anus and rectum

1.51

0.52

1.2

1.1

—

Hallux valgus (acquired)

1.42

0.52

1.2

1.1

—

Gonarthrosis,primary

150

0.75

0.51

1.2

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1.41

0.51

1.1

1.2

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1.41

0.51

1.2

—

Dental caries 1 and operation codes, only avohilmo

1.45

0.51

1.5

1.0

—

Gout, unspecified

1.46

0.50

1.0

1.4

—

Conductive and sensorineural hearing loss

142

1.27

0.50

1.3

1.1

—

Pregnancy examination and test

1.56

0.49

1.0

—

Vasomotor and allergic rhinitis

1.41

0.49

1.2

1.1

—

Diabetes medication

174

1.22

0.49

1.1

1.2

—

Benzodiazepine use

198

1.22

0.49

1.0

1.2

—

5-aminosalicylic acid

1.56

0.48

1.0

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

148

1.24

0.48

1.1

1.2

—

Malignant neoplasm, wide definition for exclusion

148

1.24

0.48

1.1

1.2

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

148

1.24

0.48

1.1

1.2

—

Other (not insulin) diabetes medications

162

1.23

0.48

1.1

1.2

—

Any mental disorder

166

1.21

0.48

1.4

1.1

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1.52

0.48

1.0

1.2

—

HSIL lesion of the cervix uteri, vagina or vulva

1.52

0.48

1.0

1.1

—

Superficial injury of head

1.52

0.48

1.0

1.1

—

Coxarthrosis

1.36

0.48

1.0

1.2

—

Postmenopausal bleeding

1.48

0.47

1.0

1.1

—

Ulcerative colitis (strict definition, require KELA)

1.49

0.47

1.0

1.3

—

Focal epilepsy

1.49

0.47

1.1

1.2

—

Melanocytic naevi

1.47

0.47

1.0

1.2

—

Thyrotoxicosis, other and/or unspecified

1.46

0.46

1.0

1.2

—

Gout, idiopatic and unspecified

1.46

0.46

1.0

1.4

—

Disorders of the thyroid gland

171

1.22

0.46

1.2

—

Viral and other specified intestinal infections

1.42

0.45

1.3

1.1

—

Other and unspecified disorders of vitreous body

1.40

0.45

1.0

1.2

—

Other abnormal products of conception

1.48

0.45

1.1

—

Type 2 diabetes

161

1.22

0.45

1.3

1.1

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

127

1.32

0.45

1.1

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1.40

0.45

1.0

1.2

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

1.39

0.44

1.3

1.1

—

Infections with a predominantly sexual mode of transmission

1.39

0.44

1.1

1.2

—

Acute alcohol intoxication, ICD10

1.37

0.44

1.7

1.1

—

Diabetes mellitus in pregnancy

0.65

0.43

1.0

—

Conjunctivitis (acute, non atopic)

1.44

0.43

1.0

1.1

—

Gestational diabetes (for exclusion)

0.65

0.43

1.0

1.1

—

Open wound of lower leg

1.61

0.43

1.0

1.1

—

Other skin changes

1.61

0.43

1.0

1.3

—

Chronic sinusitis

104

1.35

0.43

1.6

1.1

—

Covid-19 suspected case

1.43

0.42

1.9

1.1

—

Thyrotoxicosis

1.43

0.42

1.0

1.2

—

Fall on and from stairs and steps

1.43

0.42

1.3

1.2

—

All dysplastic lesions of the cervix uteri

1.43

0.42

1.0

1.1

—

Premature rupture of membranes

1.40

0.42

1.1

1.0

—

Colectomy operation

1.56

0.42

1.0

1.3

—

Insulin, fast-acting

1.38

0.42

1.2

1.1

—

Fenamates

1.53

0.42

1.2

1.1

—

Noninflammatory disorders of female genital tract

0.68

0.41

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1.43

0.41

1.0

—

Other condition

1.52

0.41

1.0

1.2

—

Benign neoplasm of other and ill-defined parts of digestive system

1.52

0.41

1.0

1.2

—

Labour and delivery complicated by umbilical cord complications

0.00

0.41

0.0

1.0

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

0.00

0.41

0.0

1.5

—

Non-small cell lung cancer, adenocarcinoma

0.00

0.41

0.0

1.5

—

Asthma mixed form (mode)

0.00

0.41

0.0

1.0

—

Vascular disorders of the intestines

0.00

0.41

0.0

1.1

—

Carcinoma in situ of skin

0.00

0.41

0.0

1.5

—

Conductive hearing loss, unspecified

0.00

0.41

0.0

1.1

—

L02BB Anti-androgens

0.00

0.41

0.0

1.5

—

Other otitis externa (chronic)

0.00

0.41

0.0

1.0

—

Chronic ulcer of skin, not elsewhere classified

0.00

0.41

0.0

1.4

—

Other and/or unspecified nontoxic goitre

0.00

0.41

0.0

1.1

—

Uterine polyps

0.00

0.41

0.0

1.1

—

Paralytic strabismus

0.00

0.40

0.0

1.4

—

Carcinoma in situ of skin

0.00

0.40

0.0

1.5

—

Other specified/unspecified hearing loss

0.00

0.40

0.0

1.1

—

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

0.00

0.40

0.0

1.5

—

Spontaneous abortion

1.36

0.40

1.1

—

Specific development disorders of speech and language

0.00

0.40

0.0

1.0

—

Migraine without aura and triptan purchases

1.47

0.40

1.4

1.1

—

Diabetic retinopathy, strict definition

1.46

0.40

1.4

1.3

—

Other osteochondropathies

0.00

0.40

0.0

1.4

—

Heterophoria

0.00

0.40

0.0

1.0

—

Nail disorders

0.00

0.40

0.0

1.4

—

Eustachian salpingitis and obstruction

0.00

0.40

0.0

1.1

—

Mental disorders, not otherwise specified

0.00

0.40

0.0

1.0

—

Female infertility, associated with anovulation

0.00

0.40

0.0

1.1

—

Other benign neoplasms of connective and other soft tissue

0.00

0.40

0.0

1.4

—

Malignant neoplasm of rectum

0.00

0.40

0.0

1.4

—

Substance abuse, excluding more controls

139

1.26

0.39

1.7

1.1

—

Speech therapy

1.31

0.39

1.3

1.2

—

Soft tissue disorders related to use, overuse and pressure

1.31

0.39

1.1

—

Speech and linguistic disorders, excluding more controls

0.00

0.39

0.0

1.0

—

Any event in cancer register

164

1.19

0.39

1.0

1.2

—

Persistent delusional disorders

0.00

0.39

0.0

1.0

—

Mixed and other personality disorders

0.00

0.39

0.0

1.0

—

Infections of genitourinary tract in pregnancy

0.00

0.39

0.0

1.1

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

0.00

0.39

0.0

1.4

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

0.00

0.39

0.0

1.4

—

Open wound of head

122

1.29

0.38

1.0

1.1

—

Sub-endpoint used in defining T1D endpoints

1.34

0.38

1.2

—

Other disorders of ear

167

1.20

0.37

1.4

1.1

—

Insulin, fast-acting or short human

1.35

0.37

1.2

—

Fracture of lower leg, including ankle

124

1.29

0.37

1.1

—

Spondylosis

1.30

0.37

1.1

—

Benign neoplasm of other and ill-defined parts of digestive system

1.35

0.37

1.0

1.3

—

Hernia of abdominal wall

116

0.69

0.36

1.0

1.2

—

Gonarthrosis, primary, with knee surgery

100

0.73

0.35

1.1

1.2

—

Endometriosis ASRM stages 1,2

1.43

0.35

1.0

1.1

—

Other and unspecified nerve root and plexus disorders, also in other diseases

1.40

0.35

1.0

1.2

—

Other disorders of patella

1.40

0.35

1.5

1.1

—

Enthesopathies of lower limb, excluding foot

1.40

0.35

1.2

1.1

—

Coxarthrosis, primary, with hip surgery

1.31

0.35

1.0

1.2

—

Open wound of wrist and hand

116

1.28

0.34

1.7

1.1

—

Melanocytic naevi

1.37

0.34

1.0

1.2

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

1.36

0.34

1.2

1.1

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

1.36

0.34

1.2

1.1

—

Foreign body on external eye

1.33

0.33

1.0

1.2

—

Migraine without aura

1.33

0.33

1.3

1.1

—

Hypertensive Heart Disease

1.33

0.33

1.2

1.1

—

Coronary angioplasty

0.69

0.33

2.3

1.1

—

Artrosis, including avohilmo

146

0.83

0.33

1.1

1.2

—

L02BG Aromatase inhibitors

1.30

0.33

1.3

1.1

—

Glucagon-like peptide-1 (GLP-1) analogues

112

1.25

0.32

1.1

1.2

—

Biguanides

163

1.17

0.32

1.1

1.2

—

Dental pulpitis 4, only avohilmo

177

1.15

0.31

1.1

—

Other degenerative diseases of the nervous system

1.33

0.31

1.1

1.0

—

Type 1 diabetes, wide definition, subgroup 1

1.32

0.30

1.3

1.1

—

Hypertensive heart and/or renal disease

1.29

0.30

1.9

1.0

—

Disorders of choroid and retina

147

1.19

0.30

1.1

1.2

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1.25

0.29

1.0

1.3

—

Other/unspecified seropositive rheumatoid arthritis

1.25

0.29

1.0

1.3

—

Type 1 diabetes, wide definition

1.25

0.29

1.3

1.1

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

0.73

0.29

1.1

1.3

—

Seropositive rheumatoid arthritis, wide

1.23

0.29

1.0

1.3

—

Chronic diseases of tonsils and adenoids

146

1.17

0.28

1.3

1.1

—

Malignant neoplasm of skin

106

0.78

0.28

1.0

1.3

—

Other diseases of hard tissues of teeth

124

1.20

0.28

1.1

1.2

—

Polyp of the female genital tract

1.26

0.28

1.0

1.1

—

Substance abuse

160

1.19

0.27

1.7

1.1

—

Irritable bowel syndrome

1.25

0.27

1.0

—

All dysplastic lesions of the cervix uteri, vagina or vulva

1.24

0.27

1.0

1.1

—

Exclusions for E4_PCOS_CONSORTIUM

122

0.82

0.27

1.1

—

Disorders of refraction and accommodation

1.23

0.27

1.1

1.2

—

Acute alcohol intoxication

1.21

0.26

1.6

1.1

—

Basal cell carcinoma, including avohilmo

101

0.78

0.26

1.0

1.3

—

Type 2 diabetes, definitions combined

156

1.15

0.25

1.3

1.1

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

0.72

0.24

1.0

1.1

—

Other obstetric conditions, not elsewhere classified

0.71

0.24

1.0

1.1

—

Irregular menses

1.24

0.24

1.2

1.1

—

Diseases of external ear

1.28

0.24

1.1

1.2

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

0.74

0.24

1.0

1.2

—

Type 2 diabetes, definitions combined, including avohilmo

156

1.14

0.23

1.3

1.1

—

Gonarthrosis

1.18

0.23

1.2

—

Other or unspecified ileus, impaction or obstruction

1.32

0.23

1.0

1.1

—

Dental pulpitis 3

1.29

0.23

1.0

1.1

—

Basal cell carcinoma

100

0.80

0.23

1.0

1.3

—

Acute appendicitis, no complications

152

1.18

0.23

1.0

1.1

—

Leisure time condition

1.28

0.23

2.4

1.3

—

Follicular cysts of skin and subcutaneous tissue

1.28

0.23

1.0

1.3

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

1.28

0.23

1.2

1.3

—

Type 2 diabetes, strict (exclude DM1)

158

1.13

0.22

1.3

1.1

—

Deviated nasal septum

1.25

0.22

1.1

1.0

—

Inflammatory diseases of female pelvic organs

101

1.19

0.22

1.1

—

Single spontaneous delivery

0.76

0.22

1.0

1.1

—

Delivery

0.76

0.22

1.0

1.1

—

Asthma/COPD (KELA code 203)

194

1.13

0.22

1.4

1.1

—

Outcome of delivery

1.19

0.21

1.0

—

Contraceptive management

0.78

0.21

1.0

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

163

1.13

0.21

1.2

1.1

—

Use of pramipexole

1.19

0.21

1.4

1.2

—

Sleep disorders, other/unspecified

0.00

0.21

0.0

1.0

—

Essential (haemorrhagic) thrombocythaemia

0.00

0.21

0.0

1.6

—

Lesion of radial nerve

0.00

0.21

0.0

1.0

—

Systemic atrophies primarily affecting the central nervous system

0.00

0.21

0.0

1.0

—

Benign neoplasm: Skin of ear and external auricular canal

0.00

0.21

0.0

1.7

—

Cyst of Bartholin Gland

0.00

0.21

0.0

1.0

—

Anankastic personality disorder

0.00

0.21

0.0

1.0

—

Noise effects on inner ear

0.00

0.21

0.0

1.6

—

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.7

—

Diffuse large B-cell lymphoma, helper endpoint

0.00

0.21

0.0

1.7

—

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.7

—

Benign neoplasm: Skin of trunk

0.00

0.21

0.0

1.6

—

Pustulosis palmaris et plantaris

0.00

0.21

0.0

1.0

—

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.6

—

Amblyopia ex anopsia

0.00

0.21

0.0

1.0

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

0.00

0.21

0.0

1.0

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

0.00

0.21

0.0

1.0

—

Scabies

0.00

0.21

0.0

1.0

—

Pustular psoriasis

0.00

0.21

0.0

1.0

—

Placenta praevia

0.00

0.21

0.0

1.0

—

Macular hole

0.00

0.21

0.0

1.7

—

Other noninflammatory disorders of cervix uteri

0.00

0.21

0.0

1.1

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

0.00

0.21

0.0

1.1

—

Malignant neoplasm of stomach

0.00

0.21

0.0

1.6

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

0.00

0.21

0.0

1.0

—

Glaucoma-related operations

0.00

0.21

0.0

1.7

—

Foreign body in respiratory tract

0.00

0.21

0.0

1.0

—

Other specified/unspecified soft tissue disorders

0.00

0.21

0.0

1.0

—

Use of biperiden

0.00

0.21

0.0

1.0

—

Oral lichen ruber planus, including avohilmo

0.00

0.21

0.0

1.1

—

Ingrowing nail

0.00

0.21

0.0

1.0

—

Tongue abnormality

0.00

0.21

0.0

1.0

—

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.7

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.6

—

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.0

—

Impacted maxillary molar

0.00

0.21

0.0

1.0

—

Emotional disorders starting during childhood or adolescence

0.00

0.21

0.0

1.0

—

Diseases of tongue

0.00

0.21

0.0

1.0

—

Carcinoma in situ of skin of other and unspecified parts of face

0.00

0.21

0.0

1.7

—

Focal brain injury

0.00

0.21

0.0

1.0

—

Persons encountering health services in circumstances related to reproduction

110

1.17

0.21

1.0

1.1

—

Crossbite

0.00

0.21

0.0

1.0

—

Coxarthrosis, primary

117

1.19

0.21

1.0

1.2

—

Diffuse large B-cell lymphoma

0.00

0.21

0.0

1.6

—

Other and unspecified injuries of ankle and foot

0.00

0.21

0.0

1.0

—

Cramp and spasm

0.00

0.21

0.0

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Coxiella burnetii Ab [Presence] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS